查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401976

2030 年神經電路市場預測：按產品類型、應用、最終用戶和地區進行的全球分析

Neuronal Circuits Market Forecasts to 2030 - Global Analysis By Product Type (Neurotechnology Devices, Neurodiagnostics, Neurotherapeutics, Electrodes and Probes and Other Product Types), Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球神經電路市場規模為 1.947 億美元，預計到 2030 年將達到 7.017 億美元，預測期內複合年成長率為 20.1%。

神經刺激設備、神經調節技術和其他用於治療帕金森氏症、憂鬱症和慢性疼痛等疾病的介入措施。成像技術、電極、探針、神經刺激設備和神經技術的進步只是眾多可用工具和解決方案的一小部分。理解、修改和利用神經系統中的神經迴路是神經迴路市場的焦點，其中包括相關技術和產品的研究、開發和商業化。

擴大神經科學研究的投資

政府機構、私人投資者和製藥公司不斷增加的資金正在推動旨在理解和修改神經網路的最尖端科技的創新和創造。這些投資支持探索神經系統疾病、大腦功能的複雜性和潛在治療方法的研究。此外，更多的資金允許研究人員進行更長時間、更深入的研究，使他們能夠開發尖端儀器和設備並發現新的見解。馬蘇。

缺乏標準化

臨床應用和研究中缺乏標準方法、方法論和報告方法抑制了結果的可比較性和再現性。這種多樣性使得理解資料和創建檢查神經元內神經迴路的標準流程變得困難。不僅機構和研究人員的合作變得更加困難，而且缺乏標準將使研究成果轉化為治療應用變得更加複雜。標準化對於確保資料的真實性和可靠性、促進跨學科合作以及加速可有效整合到醫療程序中的神經技術的開發至關重要。

人口高齡化加劇

隨著老年人口數量的增加，阿茲海默症、帕金森氏症和認知能力下降等與老齡化相關的神經系統疾病在國際上呈上升趨勢。隨著人口老化的增加，迫切需要能夠解決老年人複雜神經迴路問題的創新診斷設備、治療方法和神經刺激設備。此外，這些人口變化凸顯了神經科學研究和開發的必要性，以提供適合高齡化社會需求的解決方案。

臨床實務中的多種功效

儘管這些治療方法在治療神經系統疾病方面顯示出前景，但其有效性卻存在差異。治療結果的不可預測性是由於多種因素造成的，包括人類異質性、神經迴路的複雜結構、神經系統疾病的動態性質。這種可變性使得醫療專業人員很難預測和最大化治療效果。可靠且一致的結果需要深入了解每個大腦迴路的獨特特性、個體化的治療計劃以及進一步的研究以改進和標準化技術。

COVID-19 的影響：

與大流行相關的實驗室關閉以及將資源重新分配給與大流行相關的工作，對研究和開發造成了嚴重干擾。此外，招募患者和使用研究設施方面的困難推遲了針對神經迴路的新神經技術的臨床試驗。此外，這場流行病提高了人們對心理健康問題的認知，導致人們對神經技術的興趣和投資增加，以解決憂鬱症和焦慮等問題。

神經技術設備產業預計將在預測期內成為最大的產業

由於顯著的技術開拓以及對神經迴路在神經功能中發揮的關鍵作用的日益了解，神經技術設備佔據了最大的市場佔有率。腦機介面 (BCI)、神經介面、神經刺激設備和矯正器具只是神經技術設備這一大類眾多發展成果中的一小部分。此外，這些設備正在引領神經科學研究、治療和診斷的變革。透過修改特定的神經迴路，深部腦部刺激（DBS）和經顱磁刺激（TMS）等神經刺激設備擴大用於治療神經系統疾病。

預計馬達電路領域在預測期內將經歷最高的複合年成長率。

由於人們對運動功能複雜性的認知不斷提高以及對尖端治療方法的需求不斷增加，運動電路領域有望盈利成長。這種擴散尤其值得注意，因為針對運動迴路的神經技術的發展和使用突顯了這些迴路在運動控制和協調中所扮演的關鍵角色。此外，運動電路部分涵蓋了神經假體和腦機介面（BCI）的進展，這些技術直接與運動相關的神經電路連接，並為迷路或癱瘓的人提供運動功能。

佔有率最大的地區

亞太地區佔據了最大的佔有率，因為該地區國家透過對研發的大量投資和醫療基礎設施的快速改善而在神經技術創新領域主導地位。對神經系統疾病的了解不斷加深，以及影響神經迴路的疾病發生率不斷增加，增加了對創新診斷和治療方法的需求。此外，透過加強學術機構、研究機構和產業貢獻者之間的合作努力和夥伴關係，亞太地區正在建立一個充滿活力的神經科學研究生態系統。

複合年成長率最高的地區：

由於對研究經費、醫療基礎設施和合作研究的關注，歐洲地區預計將出現良好的成長。歐洲國家正在大力投資神經迴路研究，從而促進我們對大腦運作方式的理解和最尖端科技的發展。此外，政府對神經科學計畫的融資和策略性投資也推動了尖端神經迴路技術的發展，為研究和開發創造了良好的環境。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經電路市場：依產品類型

  • 介紹
  • 神經技術設備
  • 神經診斷
  • 神經治療
  • 電極和探針
    • 微電極陣列
    • 多電極陣列
    • 膜片鉗電極
  • 神經刺激設備
    • 深部腦部刺激（DBS）
    • 經顱磁刺激（TMS）
    • 經顱直流電刺激 (tDCS)
  • 神經傳導物質檢測裝置
  • 其他產品類型

第6章全球神經電路市場：依類型

  • 介紹
  • 認知迴路
  • 馬達電路
  • 獎勵電路
  • 感覺迴路
  • 其他類型

第7章全球神經電路市場：依應用

  • 介紹
  • 臨床診斷
  • 藥物研發發現與開發
  • 治療性介入
  • 神經假體
  • 其他用途

第8章全球神經電路市場：依最終用戶分類

  • 介紹
  • 醫院
  • 研究與開發
  • 復健中心
  • 製藥公司
  • 其他最終用戶

第9章全球神經電路市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • BIOPAC Systems, Inc
  • Blackrock Microsystems
  • Brain Vision LLC
  • Cortera Neurotechnologies, Inc
  • CortiCare, Inc
  • G.tec medical engineering GmbH
  • Inscopix, Inc
  • Neuralink Corporation
  • Neurologica Corporation
  • NeuroNexus Technologies
  • NeuroPace, Inc
  • Stoelting Co
Product Code: SMRC24496

According to Stratistics MRC, the Global Neuronal Circuits Market is accounted for $194.7 million in 2023 and is expected to reach $701.7 million by 2030 growing at a CAGR of 20.1% during the forecast period. Neurostimulation devices, neuromodulation technologies, and other interventions for the treatment of diseases including Parkinson's disease, depression, and chronic pain. Imaging technologies, electrodes, probes, neurostimulation devices, and neurotechnological advancements are only a few of the many tools and solutions available. Understanding, modifying, and using neuronal circuits in the nervous system is the focus of the market for neuronal circuits, which includes research, development, and commercialization of associated technologies and products.

Market Dynamics:

Driver:

Growing investments in neuroscience research

Innovation and the creation of cutting-edge technology aimed at understanding and modifying neuronal networks are fueled by increased funding from governmental organizations, private investors, and pharmaceutical corporations. These investments support research exploring neurological conditions, the intricacies of brain function, and potential treatment options. Additionally, more financing enables researchers to execute longer and deeper studies, which results in the development of cutting-edge instruments and gadgets as well as the discovery of novel insights.

Restraint:

Lack of standardization

The lack of standard methods, methodologies, and reporting practices in clinical applications and research inquiries impedes the comparability and reproducibility of results. This diversity makes it difficult to understand the data, which makes it challenging to build standard processes to examine neural circuits in neurons. In addition to making it more difficult for institutions and researchers to collaborate, the lack of standards makes it more complex to convert research findings into therapeutic applications. In order to ensure data authenticity and reliability, promote interdisciplinary collaboration, and accelerate the development of neurotechnologies that may be efficiently integrated into healthcare procedures, standardization is essential.

Opportunity:

Growing aging population

Age-related neurological conditions, such as Alzheimer's disease, Parkinson's disease, and cognitive decline, are on the rise internationally in correlation with the growing number of elderly individuals. Innovative diagnostic instruments, treatment approaches, and neurostimulation devices that can address the complexities of older people's neural circuits are desperately needed as the aging population grows. Moreover, this shift in the population emphasizes the need for neuroscience research and development to provide solutions that are specifically customized to the demands of the aging population.

Threat:

Variable efficacy in clinical settings

Although treating neurological illnesses with these therapies indicates promise, variations in their efficacy may exist. The unpredictable nature of treatment outcomes is attributed to various factors, including human heterogeneity, the complex structure of neural circuits, and the dynamic nature of neurological disorders. The wider use of these technologies is hampered by the variability that presents difficulties for healthcare professionals in anticipating and maximizing the treatment response. Deeper knowledge of the unique properties of each brain circuit, individualized treatment plans, and more research to improve and standardize techniques are necessary for achieving reliable and consistent results.

COVID-19 Impact:

The pandemic-related closure of laboratories and the reallocation of resources toward pandemic-related efforts caused significant disruptions to research and development. Additionally, difficulties in attracting patients and gaining access to research sites caused delays in clinical trials for new neurotechnologies targeting neuronal circuits. Furthermore, the increased awareness of mental health issues brought on by the pandemic also resulted in increased interest in and investment in neurotechnologies addressing conditions like depression and anxiety.

The neurotechnology devices segment is expected to be the largest during the forecast period

Due to remarkable technological developments and an increasing understanding of the critical role neural circuits play in neurological functioning, neurotechnology devices held the largest market share. Brain-computer interfaces (BCIs), neural interfaces, neurostimulation devices, and neuroprosthetics are just a few instances among the many developments that are included under the broad category of neurotechnology devices. Additionally, these gadgets are leading the way in transforming neuroscience research, therapies, and diagnostics. By modifying particular neural circuits, neurostimulation devices like deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) are being used more often to treat neurological conditions.

The motor circuits segment is expected to have the highest CAGR during the forecast period

Because of the rising awareness of the complexity of motor function and the increasing demand for cutting-edge therapeutic treatments, the motor circuits segment is expected to grow profitably. The development and use of neurotechnologies that target motor circuits, which emphasize the critical role these circuits play in movement control and coordination, is especially notable for this surge. Furthermore, the Motor Circuits portion covers advancements in neuroprosthetics and brain-computer interfaces (BCIs) that directly interface with motor-related neural circuits, providing motor function for individuals who lose their limbs or are paralyzed.

Region with largest share:

The Asia Pacific area held the largest share because of the region's countries' leading positions in the field of neurotechnology innovation, which have been established by significant investments in research and development as well as rapid improvements in healthcare infrastructure. The need for innovative diagnostic and treatment approaches has increased due to an increasing understanding of neurological illnesses and the incidence of illnesses affecting neural circuits. Furthermore, a vibrant ecosystem for neuroscience research is being developed in the Asia-Pacific area through a rise in cooperative initiatives and partnerships between academic institutions, research organizations, and industrial contributors.

Region with highest CAGR:

Because of its heavy emphasis on research funding, healthcare infrastructure, and collaborations, the Europe area is expected to have lucrative growth. European nations have invested heavily in neural circuit research, resulting in advances in the understanding of how the brain works as well as the development of cutting-edge technologies. Furthermore, the growth of cutting-edge neural circuit technology has been fueled by government financing and strategic investments in neuroscience initiatives, which have established a favorable environment for research and development.

Key players in the market:

Some of the key players in Neuronal Circuits market include BIOPAC Systems, Inc, Blackrock Microsystems, Brain Vision LLC, Cortera Neurotechnologies, Inc, CortiCare, Inc, G.tec medical engineering GmbH, Inscopix, Inc, Neuralink Corporation , Neurologica Corporation, NeuroNexus Technologies, NeuroPace, Inc and Stoelting Co.

Key Developments:

In January 2023, NeuroLogica Announces a Research Partnership with the University of Dundee Using State-of-the-Art Photon Counting Detector Technology. The partnership aims to push the boundaries of medical imaging, impact patient outcomes and increase the quality of life for Scottish patients at Dundee.

In November 2022, NeuroLogica Announces FDA 510(k) Clearance of BodyTom 64. The BodyTom 64 was designed to help healthcare professionals bring the power of advanced imaging directly to their patients.

Product Types Covered:

  • Neurotechnology Devices
  • Neurodiagnostics
  • Neurotherapeutics
  • Electrodes and Probes
  • Neurostimulation Devices
  • Neurotransmitter Detection Devices
  • Other Product Types

Types Covered:

  • Cognitive Circuits
  • Motor Circuits
  • Reward Circuits
  • Sensory Circuits
  • Other Types

Applications Covered:

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Therapeutic Interventions
  • Neuroprosthetics
  • Other Applications

End Users Covered:

  • Hospitals
  • Research and Development
  • Rehabilitation Centers
  • Pharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neuronal Circuits Market, By Product Type

  • 5.1 Introduction
  • 5.2 Neurotechnology Devices
  • 5.3 Neurodiagnostics
  • 5.4 Neurotherapeutics
  • 5.5 Electrodes and Probes
    • 5.5.1 Microelectrode arrays
    • 5.5.2 Multielectrode arrays
    • 5.5.3 Patch-clamp electrodes
  • 5.6 Neurostimulation Devices
    • 5.6.1 Deep Brain Stimulation (DBS)
    • 5.6.2 Transcranial Magnetic Stimulation (TMS)
    • 5.6.3 Transcranial Direct Current Stimulation (tDCS)
  • 5.7 Neurotransmitter Detection Devices
  • 5.8 Other Product Types

6 Global Neuronal Circuits Market, By Type

  • 6.1 Introduction
  • 6.2 Cognitive Circuits
  • 6.3 Motor Circuits
  • 6.4 Reward Circuits
  • 6.5 Sensory Circuits
  • 6.6 Other Types

7 Global Neuronal Circuits Market, By Application

  • 7.1 Introduction
  • 7.2 Clinical Diagnostics
  • 7.3 Drug Discovery and Development
  • 7.4 Therapeutic Interventions
  • 7.5 Neuroprosthetics
  • 7.6 Other Applications

8 Global Neuronal Circuits Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Research and Development
  • 8.4 Rehabilitation Centers
  • 8.5 Pharmaceutical Companies
  • 8.6 Other End Users

9 Global Neuronal Circuits Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 BIOPAC Systems, Inc
  • 11.2 Blackrock Microsystems
  • 11.3 Brain Vision LLC
  • 11.4 Cortera Neurotechnologies, Inc
  • 11.5 CortiCare, Inc
  • 11.6 G.tec medical engineering GmbH
  • 11.7 Inscopix, Inc
  • 11.8 Neuralink Corporation
  • 11.9 Neurologica Corporation
  • 11.10 NeuroNexus Technologies
  • 11.11 NeuroPace, Inc
  • 11.12 Stoelting Co

List of Tables

  • Table 1 Global Neuronal Circuits Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neuronal Circuits Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Neuronal Circuits Market Outlook, By Neurotechnology Devices (2021-2030) ($MN)
  • Table 4 Global Neuronal Circuits Market Outlook, By Neurodiagnostics (2021-2030) ($MN)
  • Table 5 Global Neuronal Circuits Market Outlook, By Neurotherapeutics (2021-2030) ($MN)
  • Table 6 Global Neuronal Circuits Market Outlook, By Electrodes and Probes (2021-2030) ($MN)
  • Table 7 Global Neuronal Circuits Market Outlook, By Microelectrode arrays (2021-2030) ($MN)
  • Table 8 Global Neuronal Circuits Market Outlook, By Multielectrode arrays (2021-2030) ($MN)
  • Table 9 Global Neuronal Circuits Market Outlook, By Patch-clamp electrodes (2021-2030) ($MN)
  • Table 10 Global Neuronal Circuits Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
  • Table 11 Global Neuronal Circuits Market Outlook, By Deep Brain Stimulation (DBS) (2021-2030) ($MN)
  • Table 12 Global Neuronal Circuits Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2021-2030) ($MN)
  • Table 13 Global Neuronal Circuits Market Outlook, By Transcranial Direct Current Stimulation (tDCS) (2021-2030) ($MN)
  • Table 14 Global Neuronal Circuits Market Outlook, By Neurotransmitter Detection Devices (2021-2030) ($MN)
  • Table 15 Global Neuronal Circuits Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 16 Global Neuronal Circuits Market Outlook, By Type (2021-2030) ($MN)
  • Table 17 Global Neuronal Circuits Market Outlook, By Cognitive Circuits (2021-2030) ($MN)
  • Table 18 Global Neuronal Circuits Market Outlook, By Motor Circuits (2021-2030) ($MN)
  • Table 19 Global Neuronal Circuits Market Outlook, By Reward Circuits (2021-2030) ($MN)
  • Table 20 Global Neuronal Circuits Market Outlook, By Sensory Circuits (2021-2030) ($MN)
  • Table 21 Global Neuronal Circuits Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 22 Global Neuronal Circuits Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Neuronal Circuits Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 24 Global Neuronal Circuits Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 25 Global Neuronal Circuits Market Outlook, By Therapeutic Interventions (2021-2030) ($MN)
  • Table 26 Global Neuronal Circuits Market Outlook, By Neuroprosthetics (2021-2030) ($MN)
  • Table 27 Global Neuronal Circuits Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Neuronal Circuits Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Neuronal Circuits Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Neuronal Circuits Market Outlook, By Research and Development (2021-2030) ($MN)
  • Table 31 Global Neuronal Circuits Market Outlook, By Rehabilitation Centers (2021-2030) ($MN)
  • Table 32 Global Neuronal Circuits Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 33 Global Neuronal Circuits Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.